FDA issued an immediately in effect guidance, Enforcement Policy for Remote Digital Pathology Devices during the Coronavirus Disease 2019 (Covid-19) Public Health Emergency, to help expand the availability of devices for remote reviewing and reporting of scanned digital images of pathology slides during this public health emergency.
Increased availability of such devices may help to facilitate continuity of patient care by preventing disruptions to critical pathology services rendered by clinical laboratories, hospitals, and other healthcare facilities, and reduce healthcare personnel contact and risk of exposure to SARS-CoV-2.

Read more from FDA.